Compounds > 3,4-methylenedioxyamphetamine

3,4-methylenedioxyamphetamine and bemesetron

3,4-methylenedioxyamphetamine has been researched along with bemesetron in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilsky, EJ; Reid, LD1
Bilsky, EJ; Delconte, JD; Hubbell, CL; Reid, LD1

Other Studies

2 other study(ies) available for 3,4-methylenedioxyamphetamine and bemesetron

ArticleYear
MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 39, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Conditioning, Operant; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin Antagonists; Tropanes

1991
MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Conditioning, Operant; Defecation; Ejaculation; Endorphins; Male; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Inbred Strains; Serotonin Antagonists; Tropanes; Urination

1991